Now showing items 1-3 of 3
Acyline: the first study in humans of a potent, new gonadotropin-releasing hormone antagonist
(Endocrine Society, 2002-07)
Acyline is a novel GnRH antagonist found in animal studies to be a potent suppressor of circulating gonadotropin and testosterone (T) levels. We conducted the first study of acyline administration to humans. Eight healthy, eugonadal young men were administered a series of acyline injections (0, ...
Low dose of cyproterone acetate and testosterone enanthate for contraception in men
(Oxford University Press, 1998-05)
After a control phase, 10 normal men received cyproterone acetate (CPA) at a dose of 25 mg/day (CPA-25; n=5) or 12.5 mg/day (CPA-12.5; n=5) plus testosterone enanthate (TE) 100 mg/week, for 16 weeks. Throughout the study sperm counts were performed every 2 weeks, and luteinizing hormone (LH), ...
Commuter Mobility versus Work-zone Safety: An Empirical Study using Data Mining of Anonymous User Generated Trip Information
The two primary considerations for highway work-zones are its effect on commuter mobility and worker safety which are often spoken of together. However, it must be noted that they conflict with each other. This research aims to study this generally inverse relationship and develop a Decision Support System (DSS) for work-zone ...